Clinical Trials Logo

Clinical Trial Summary

This phase II trial studies how well 18F-FSPG positron emission tomography (PET)/computed tomography (CT) work in diagnosing early lung cancer in patients with lung nodules. PET imaging with an imaging agent called 18F-FDG is often used in combination with a PET/CT scanner to evaluate cancers. Giving 18F-FSPG before a PET/CT scan may work better in helping researchers diagnose early lung cancer in patients with lung nodules.


Clinical Trial Description

PRIMARY OBJECTIVES: I. Comparison of fluorine F 18 L-glutamate derivative BAY94-9392 (18F-FSPG) accumulation with fludeoxyglucose F-18 (18F-FDG) accumulation to assess whether (4S)-4-(3-18F-Fluoropropyl)-L-Glutamate (18F-FSPG)-PET is better at discriminating between benign and malignant nodules. SECONDARY OBJECTIVES: I. To develop and validate early lung cancer detection biomarkers that would directly impact the growing need to integrate imaging and non-invasive molecular diagnostics for indeterminate pulmonary nodules and allow physicians to avoid unnecessary invasive procedures in patients with benign lung disease. OUTLINE: Patients receive 18F-FSPG intravenously (IV) and, undergo a PET/CT scan over 30-60 minutes. Within 24 hours-14 days, patients receive 18F-FDG and undergo a second PET/CT scan over 30-60 minutes. After completion of study, patients are followed up within 24-72 hours. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03824535
Study type Interventional
Source Stanford University
Contact Mahima Goel
Phone 650-723-0371
Email mahimag@stanford.edu
Status Recruiting
Phase Phase 2
Start date February 4, 2019
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Terminated NCT05066776 - Liquid Biopsy With PET/CT Versus PET/CT Alone in Diagnosis of Small Lung Nodules
Recruiting NCT06004440 - Real World Registry for Use of the Ion Endoluminal System
Enrolling by invitation NCT01465425 - Extracolonic Findings on Computed Tomography (CT) Colonography
Completed NCT01958931 - Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer N/A
Completed NCT02090816 - Combined Liver and Right Lung Resection for Colorectal Metastases by Means of J-shaped Thoracophrenolaparotomy N/A
Completed NCT01566682 - A Multi-Center Trial of the ProLung Testâ„¢
Not yet recruiting NCT04047186 - Neoadjuvant Immunotherapy in Early Stage Non-small-cell Lung Cancer Presenting as Synchronous Ground-glass Nodules Phase 2
Completed NCT02169271 - Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules Phase 2
Terminated NCT02983903 - Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions N/A
Recruiting NCT02726633 - Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer N/A
Completed NCT01397045 - Fast Track Rehabilitation Following Video-assisted Lung Segmentectomy N/A
Recruiting NCT05171491 - LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
Withdrawn NCT05804435 - iNodâ„¢ Ultrasound-Guided Needle Biopsy System Study N/A
Recruiting NCT02468609 - Diagnostic Value of Ultralow-dose Computed Tomography for the Detection of Pulmonary Nodules and Lung Parenchym Alterations Compared to Standard-dose CT N/A
Completed NCT03795181 - Prediction Model for Multiple Pulmonary Nodules
Not yet recruiting NCT04192201 - A Real-world Study for Patients With Multiple Pulmonary Ground-glass Nodules
Completed NCT00963651 - GE Healthcare VolumeRAD Lung Nodule Detection Study N/A
Enrolling by invitation NCT04574518 - Teachable Moment to Opt-out of Tobacco: Interactive Voice Response Quit Line for Veteran Active Smokers With Lung Nodules N/A
Not yet recruiting NCT03487952 - Evaluation of Lung Nodule Detection With Artificial Intelligence Assisted Computed Tomography in North China